rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2005-2-8
|
pubmed:abstractText |
Migraine is a common, disabling condition that has a significant impact on patients and relatives, and is a considerable economic burden on society. Migraine patients want fast-acting treatments with high efficacy. Previous studies have demonstrated that orally administered formulations of zolmitriptan are rapidly and highly effective in the acute treatment of migraine. The objective of this study was to assess the efficacy, speed of onset and tolerability of the nasal spray formulation of zolmitriptan in migraine treatment.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1172-7047
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
125-36
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:15697326-Administration, Intranasal,
pubmed-meshheading:15697326-Adolescent,
pubmed-meshheading:15697326-Adult,
pubmed-meshheading:15697326-Aged,
pubmed-meshheading:15697326-Double-Blind Method,
pubmed-meshheading:15697326-Drug Tolerance,
pubmed-meshheading:15697326-Female,
pubmed-meshheading:15697326-Humans,
pubmed-meshheading:15697326-Male,
pubmed-meshheading:15697326-Middle Aged,
pubmed-meshheading:15697326-Migraine Disorders,
pubmed-meshheading:15697326-Oxazolidinones,
pubmed-meshheading:15697326-Pain Measurement,
pubmed-meshheading:15697326-Reaction Time,
pubmed-meshheading:15697326-Recurrence,
pubmed-meshheading:15697326-Serotonin Receptor Agonists,
pubmed-meshheading:15697326-Sumatriptan,
pubmed-meshheading:15697326-Time Factors,
pubmed-meshheading:15697326-Treatment Outcome,
pubmed-meshheading:15697326-Tryptamines
|
pubmed:year |
2005
|
pubmed:articleTitle |
Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.
|
pubmed:affiliation |
Department of Neurology, Mayo Clinic College of Medicine, Scottsdale, Arizona 85259, USA. Dodick.David@mayo.edu
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|